will compounded tirzepatide be banned FDA moves to remove GLP-1 medications from 503B Bulks List FDA officials warn of fake

If you are located in New Mexico, Michigan, or Louisiana, you will consult with your provider via live video

Two people can weigh the same and look and function very differently

A prespecified analysis of the SELECT trial examined the relationship between changes in adiposity measures (body weight and waist circumference) and cardiovascular outcomes among 17,604 patients with obesity or overweight and established cardiovascular disease but without diabetes.[1] The analysis revealed that cardiovascular outcomes were similar among semaglutide-treated patients who did or did not lose at least 5% of their baseline body weight, and that semaglutide consistently reduced major adverse cardiovascular events across the full spectrum of baseline body mass index values

Hows your kidney function